The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for CA Maggi


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.EBI
University of Naples&Quot;Federico Ii&Quot
Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine.EBI
Menarini Ricerche
hNK2 receptor antagonists. The use of intramolecular hydrogen bonding to increase solubility and membrane permeability.EBI
Menarini Ricerche
Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor.EBI
Menarini Ricerche
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.EBI
University of Naples Federico Ii
A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.EBI
Institute of Mutagenesis and Differentiation
Insertion of 2-carboxysuccinate and tricarballylic acid fragments into cyclic-pseudopeptides: new antagonists for the human tachykinin NK-2 receptor.EBI
Menarini Ricerche S.P.A. Laboratori Di Firenze
 
Synthesis and biological activity of new bradykinin pseudopeptide B1 receptor agonists containing alkylic spacersEBI
TBA
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.EBI
Menarini Ricerche
Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.EBI
Menarini Ricerche Pomezia
4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.EBI
Menarini Ricerche Pomezia
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.EBI
Menarini Ricerche Pomezia
Antiproliferative and differentiating activities of a novel series of histone deacetylase inhibitors.EBI
Menarini Ricerche
Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists.EBI
Menarini Ricerche
Insertion of an aspartic acid moiety into cyclic pseudopeptides: synthesis and biological characterization of potent antagonists for the human Tachykinin NK-2 receptor.EBI
Menarini Ricerche
A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.EBI
University of Naples Federico Ii
Monocyclic human tachykinin NK-2 receptor antagonists as evolution of a potent bicyclic antagonist: QSAR and site-directed mutagenesis studies.EBI
Menarini Ricerche
Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists.EBI
Menarini Ricerche